期刊
PSYCHOPHARMACOLOGY
卷 237, 期 7, 页码 2111-2124出版社
SPRINGER
DOI: 10.1007/s00213-020-05522-y
关键词
Gelsemine; beta-Amyloid; Alzheimer's disease; Tau; Neuroinflammation
资金
- National Natural Science Foundation of China [81870853]
- Ningbo Sci & Tech Project for Common Wealth [2017C50042]
- Zhejiang Key Laboratory of Pathophysiology [201804]
- Open Project Program of State Key Laboratory of Food Nutrition and Safety, Tianjin University of Science Technology [SKLFNS-KF-201806]
- Ningbo municipal innovation team of life science and health [2015C110026]
- LiDakSum Marine Biopharmaceutical Development Fund
- K. C. Wong Magna Fund in Ningbo University
Introduction Gelsemine is a natural alkaloid extracted from Gelsemium elegans Benth., a traditional Chinese medicinal herb. Gelsemine has been shown to penetrate the brain, and could produce neurological activities, such as anxiolytic and neuralgia-alleviating effects, suggesting that this natural compound might be used for treating nervous system diseases. Results In this study, we have found, for the first time, that gelsemine at low concentrations (5-10 mu g/kg) significantly alleviated cognitive impairments induced by beta-amyloid (A beta) oligomer, a main neurotoxin of Alzheimer's disease (AD). In addition, gelsemine substantially prevented A beta oligomer-induced over-activation of microglia and astrocytes, indicating that gelsemine might reduce AD-related gliosis. Consistently, gelsemine inhibited the over-expression of pro-inflammatory cytokines, including interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha), in the brain of mice. Moreover, gelsemine largely increased the expression of pSer9-glycogen synthase kinase-3 beta (GSK3 beta), and decreased the hyper-phosphorylation of tau protein as evidenced by Western blotting analysis. Furthermore, gelsemine prevented A beta oligomer-induced reduction of PSD-95, a representative post-synaptic protein. Conclusion All these results directly demonstrated the anti-A beta oligomer neuroprotective properties of gelsemine, opening a novel perspective for the development of gelsemine-based therapeutics against A beta-associated neurodegeneration disorders, including AD in particular.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据